GlassScriptPhysician profile
Erin N Hill
NPI 1154484269
$1,515.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $543 · 2021: $396 · 2022: $18.84.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $210.40 | 2019-2021 | |
| Abbvie INC. | $176.38 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.13 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $125.12 | 2021 | |
| Novo Nordisk INC | $120.32 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $103.71 | 2019-2021 | |
| Pfizer INC. | $88.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $70.92 | 2019-2020 | |
| Astellas Pharma US INC | $64.16 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $55.22 | 2020 | |
| Amgen INC. | $48.40 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $45.78 | 2019-2021 | |
| Daiichi Sankyo INC. | $40.17 | 2019 | |
| Allergan, INC. | $36.98 | 2019-2020 | |
| Therapeuticsmd, INC. | $36.37 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35.23 | 2019 | |
| Amarin Pharma, INC. | $31.71 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $17.14 | 2021 | |
| Ethicon US, LLC | $16.61 | 2019 | |
| Virtus Pharmaceuticals LLC | $16.18 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.17 | 2019 | |
| Evofem Biosciences, INC. | $14.91 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.47 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.